Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
clinical trials
life sciences
national blog main
biotech
boston blog main
boston top stories
calcitonin gene-related peptide
cholesterol
chronic migraine
data
drugs
eli lilly
episodic migraine
fda
inclisiran
indiana
indiana blog main
indiana top stories
ldl
mark timney
migraine
mt sinai hospital
national top stories
new york
new york blog main
new york top stories
pcsk9
peter wijngaard
praluent
prashant vaishnava
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
teva pharmaceutical
the institute for clinical and economic review
the medicines co.
What
announced
2
×
drug
medicines
aces
approval
approved
big
ceo
cholesterol
class
decision
developed
eli
fda
flexible
headache
inclisiran
key
late
lilly
lowering
marks
meant
medco
medicine
migraine
nasdaq
new
open
pain
passed
prevent
pricing
starts
taken
test
thursday
twice
week
won
Language
unset
Current search:
announced
×
amgen
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines